<VariationArchive VariationID="201559" VariationName="NM_000335.5(SCN5A):c.2533del (p.Val845fs)" VariationType="Deletion" Accession="VCV000201559" Version="19" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-05-01" DateCreated="2016-05-29" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="196944" VariationID="201559">
      <GeneList>
        <Gene Symbol="SCN5A" FullName="sodium voltage-gated channel alpha subunit 5" GeneID="6331" HGNC_ID="HGNC:10593" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38548062" stop="38649687" display_start="38548062" display_stop="38649687" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38589552" stop="38691163" display_start="38589552" display_stop="38691163" Strand="-" />
          </Location>
          <OMIM>600163</OMIM>
          <Haploinsufficiency last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-06-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN5A">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000335.5(SCN5A):c.2533del (p.Val845fs)</Name>
      <CanonicalSPDI>NC_000003.12:38585944:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="38585945" stop="38585945" display_start="38585945" display_stop="38585945" variantLength="1" positionVCF="38585944" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="38627436" stop="38627436" display_start="38627436" display_stop="38627436" variantLength="1" positionVCF="38627435" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V845fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.38627437del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.38627437del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.38585946del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.38585946del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008934.1" sequenceAccession="NG_008934" sequenceVersion="1" change="g.68728del">
            <Expression>NG_008934.1:g.68728del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000335.5" sequenceAccession="NM_000335" sequenceVersion="5" change="c.2533del" MANESelect="true">
            <Expression>NM_000335.5:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000326.2" sequenceAccession="NP_000326" sequenceVersion="2" change="p.Val845fs">
            <Expression>NP_000326.2:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099404.2" sequenceAccession="NM_001099404" sequenceVersion="2" change="c.2533del" MANEPlusClinical="true">
            <Expression>NM_001099404.2:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092874.1" sequenceAccession="NP_001092874" sequenceVersion="1" change="p.Val845fs">
            <Expression>NP_001092874.1:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099405.2" sequenceAccession="NM_001099405" sequenceVersion="2" change="c.2533del">
            <Expression>NM_001099405.2:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001092875.1" sequenceAccession="NP_001092875" sequenceVersion="1" change="p.Val845fs">
            <Expression>NP_001092875.1:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160160.2" sequenceAccession="NM_001160160" sequenceVersion="2" change="c.2533del">
            <Expression>NM_001160160.2:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153632.1" sequenceAccession="NP_001153632" sequenceVersion="1" change="p.Val845fs">
            <Expression>NP_001153632.1:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160161.2" sequenceAccession="NM_001160161" sequenceVersion="2" change="c.2533del">
            <Expression>NM_001160161.2:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153633.1" sequenceAccession="NP_001153633" sequenceVersion="1" change="p.Val845fs">
            <Expression>NP_001153633.1:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354701.2" sequenceAccession="NM_001354701" sequenceVersion="2" change="c.2533del">
            <Expression>NM_001354701.2:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341630.1" sequenceAccession="NP_001341630" sequenceVersion="1" change="p.Val845fs">
            <Expression>NP_001341630.1:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.3" sequenceAccession="NM_198056" sequenceVersion="3" change="c.2533del">
            <Expression>NM_198056.3:c.2533del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_932173.1" sequenceAccession="NP_932173" sequenceVersion="1" change="p.Val845fs">
            <Expression>NP_932173.1:p.Val845fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_289" sequenceAccession="LRG_289">
            <Expression>LRG_289:g.68728del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000335.4" sequenceAccession="NM_000335" sequenceVersion="4" change="c.2533delG">
            <Expression>NM_000335.4:c.2533delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198056.2" sequenceAccession="NM_198056" sequenceVersion="2" change="c.2533delG">
            <Expression>NM_198056.2:c.2533delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099404.1" sequenceAccession="NM_001099404" sequenceVersion="1" change="c.2533del">
            <Expression>NM_001099404.1:c.2533del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_289t3" sequenceAccession="LRG_289t3">
            <Expression>LRG_289t3:c.2533del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA016249" DB="ClinGen" />
        <XRef Type="rs" ID="794728912" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000335.5(SCN5A):c.2533del (p.Val845fs) AND not provided" Accession="RCV000183153" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-26" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.2533del (p.Val845fs) AND Cardiovascular phenotype" Accession="RCV000621392" Version="3">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.2533del (p.Val845fs) AND Brugada syndrome" Accession="RCV000614105" Version="9">
        <ClassifiedConditionList TraitSetID="9317">
          <ClassifiedCondition DB="MedGen" ID="C1142166">Brugada syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-12-12" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000335.5(SCN5A):c.2533del (p.Val845fs) AND Brugada syndrome 1" Accession="RCV003147381" Version="1">
        <ClassifiedConditionList TraitSetID="2573">
          <ClassifiedCondition DB="MedGen" ID="C4551804">Brugada syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-26" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2016-05-29" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20129283</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22789973</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32009526</ID>
        </Citation>
        <DescriptionHistory Dated="2018-04-09">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2573" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="541" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Right bundle branch block, ST segment elevation, and sudden death syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Brugada syndrome 1</ElementValue>
                <XRef ID="MONDO:0011001" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BRGDA1</ElementValue>
                <XRef Type="MIM" ID="601144" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BrS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads V1-V3 on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood, although age at diagnosis may range from infancy to late adulthood. The mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the first year of life without an identifiable cause) and sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include first-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome.</Attribute>
                <XRef ID="NBK1517" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301690</ID>
                <ID Source="BookShelf">NBK1517</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="130" DB="Orphanet" />
              <XRef ID="C4551804" DB="MedGen" />
              <XRef ID="MONDO:0011001" DB="MONDO" />
              <XRef Type="MIM" ID="601144" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9317" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16748" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sudden Unexplained Death Syndrome</ElementValue>
                <XRef ID="D053840" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudden Unexplained Nocturnal Death Syndrome (SUNDS)</ElementValue>
                <XRef ID="D053840" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Brugada syndrome</ElementValue>
                <XRef ID="Brugada+Syndrome/982" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015263" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS601144" DB="OMIM" />
                <XRef ID="418818005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudden unexpected nocturnal death syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudden unexplained nocturnal death syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BrS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SUNDS</ElementValue>
                <XRef Type="MIM" ID="601144" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1030" />
                <XRef ID="1030" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads V1-V3 on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood, although age at diagnosis may range from infancy to late adulthood. The mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the first year of life without an identifiable cause) and sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include first-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome.</Attribute>
                <XRef ID="NBK1517" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301690</ID>
                <ID Source="BookShelf">NBK1517</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <XRef ID="130" DB="Orphanet" />
              <XRef ID="C1142166" DB="MedGen" />
              <XRef ID="MONDO:0015263" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS601144" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1789234" SubmissionDate="2019-05-21" DateLastUpdated="2019-05-22" DateCreated="2019-05-22">
        <ClinVarSubmissionID localKey="SUB5652954" submittedAssembly="GRCh37" title="SUB5652954" />
        <ClinVarAccession Accession="SCV000914210" DateUpdated="2019-05-22" DateCreated="2019-05-22" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-04-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A">
              <Name>sodium voltage-gated channel alpha subunit 5</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000335.4:c.2533delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Brugada syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1142166" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5652954</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1412926" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-14" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="76959607|Orphanet:ORPHA130" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000731766" DateUpdated="2019-08-14" DateCreated="2018-04-09" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20129283</ID>
          </Citation>
          <Comment>The p.Val845fs variant in SCN5A has been reported in 1 individual with suspected Brugada syndrome (Kapplinger 2010) and has also been reported by other clinical laboratories in ClinVar (Variation ID: 201559). It was absent from large popula tion studies. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 845 and leads to a premature termination codon 2 amino acids downstream. This alteration is then predicted t o lead to a truncated or absent protein. Loss of function variants in SCN5A are typically associated with Brugada syndrome although overlapping presentations in cluding other SCN5A related phenotypes (Long QT syndrome) have been described (R emme 2013). In summary, although additional studies are required to fully establ ish its clinical significance, the p.Val845fs variant is likely pathogenic. ACMG /AMP Criteria applied: PVS1, PM2 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_198056.2:EXON 16</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_198056.2:c.2533delG</Name>
            <Name>p.Val845CysfsX2</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.38627436delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA130" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348979</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7160097" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2023-03-11">
        <ClinVarSubmissionID localKey="20030|OMIM:601144" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003836251" DateUpdated="2023-03-11" DateCreated="2023-03-11" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001099404.1:c.2533del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601144" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="431868" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2015-07-05">
        <ClinVarSubmissionID localKey="GDXSV:311777" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000235569" DateUpdated="2023-11-25" DateCreated="2015-07-05" Type="SCV" Version="13" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Reported in patients with Brugada syndrome or a prolonged QTc (PMID: 20129283, 32009526, 34649698); Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 20129283, 30662450, 31447099, 34649698, 32009526)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:56333</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198056.2:c.2533del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_104_20220504054205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_106_20220511054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1469954" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="352315|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000760219" DateUpdated="2024-02-14" DateCreated="2018-04-09" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20129283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22789973</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20129283</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val845Cysfs*2) in the SCN5A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN5A are known to be pathogenic (PMID: 20129283, 22789973). This premature translational stop signal has been observed in individual(s) with Brugada syndrome (PMID: 20129283). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 201559).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.38627436del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1436650" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-04-14">
        <ClinVarSubmissionID localKey="a638369|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000738104" DateUpdated="2024-05-01" DateCreated="2018-04-14" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20129283</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32009526</ID>
          </Citation>
          <Comment>The c.2533delG pathogenic mutation, located in coding exon 15 of the SCN5A gene, results from a deletion of one nucleotide at nucleotide position 2533, causing a translational frameshift with a predicted alternate stop codon (p.V845Cfs*2). This alteration has been detected in multiple individuals with confirmed or suspected Brugada syndrome (Kapplinger JD et al. Heart Rhythm, 2010 Jan;7:33-46; Pottinger TD et al. J Am Heart Assoc, 2020 02;9:e013808). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN5A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198056.2:c.2533delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1789234" TraitType="Disease" MappingType="Name" MappingValue="Brugada syndrome" MappingRef="Preferred">
        <MedGen CUI="C1142166" Name="Brugada syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="431868" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1469954" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1436650" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7160097" TraitType="Disease" MappingType="XRef" MappingValue="601144" MappingRef="OMIM">
        <MedGen CUI="C4551804" Name="Brugada syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1412926" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA130" MappingRef="Orphanet">
        <MedGen CUI="C1142166" Name="Brugada syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

